Please see below to view details for this session presenter

Curt Bilby, PhD (Moderator)

President and Chief Executive Officer, Terapio

Dr. Bilby has been the President and CEO of Terapio since 2007 and has over twenty years of executive leadership experience in the biotechnology, healthcare and information technology sectors both domestically and in Europe. Previously, Dr. Bilby was President and CEO of Seahawk Biosystems Corporation which developed a biosensor based magnetic biochip technology developed at the Naval Research Laboratory. Prior to that, he was the Chairman and CEO of Evacyte Corporation, a company developing laser-based cancer detection and cell diagnostics using the internationally recognized Optical Cell Stretcher technology developed at The University of Texas at Austin. Dr. Bilby also served as the Président-Directeur Général of the multi-national healthcare company Eurimed, S.A. headquartered in Paris, France. Dr. Bilby has engineering degrees from Rose-Hulman Institute of Technology and Auburn University and conducted his doctoral work at The University of Texas at Austin. Of note is his selection as a Distinguished Young Alumnus of Rose-Hulman where he was also awarded an honorary doctorate.